B: Functional biointerfaces
The symposium addresses the growing interest of materials scientists in the creation, characterization, and control of processes at functional biointerfaces, i. e, the interfaces between biomolecules, cells, tissues or complex biological systems with other materials. The aim of this symposium is to exchange information about the fundamental understanding, characterization, control and engineering of these interfaces in a thought provoking, stimulating atmosphere. This is not only because of the intellectual challenges of the exciting interdisciplinary field of materials science but also because materials scientists, physicists, chemists, biologists, engineers and medical doctors are facing more and more situations where materials are confronted with challenging biological environments. Therefore, a need exists to develop and spread knowledge in this area. The aim of this symposium is, therefore, to address the need to design, create, characterize and test functional biointerfaces and to develop structure-property relationships for these functional biointerfaces.
Hot topics to be covered by the symposium: Subject areas of this symposium include but are not limited to: biointerfaces of medical implants; proteins, polysaccharids and other biomolecules at biointerfaces; engineered micro and nanoenvironments of cells for regenerative medicine; structuring and functionalisation of biointerfaces; molecular cell biology at biointerfaces; antimicrobial biointerfaces; biomineralization at biointerfaces; nanoparticle, nanotube and nanofibre interfaces; gene and drug delivery at biointerfaces; therapy and probes in bioenvironments; sensors and devices; pathogen detection at biointerfaces; characterization of biointerfaces including probe methods; biointerfaces in nature and bioinspired biointerfaces; computational modelling of biointerfaces.
Target groups of the symposium:
Materials scientists, physicists, chemists, biochemists, engineers, biologists, microbiologists, pharmaceutical scientists, and medical professionals from fundamental and applied research as well as from industry and clinical backgrounds.
List of invited speakers:
• (PBSu) is a kind of novel biodegradable aliphatic polyester synthesized by copolycondensation. It possesses good processability, superior mechanical properties, harmless degradation products (CO2 and H2O), and adjustable degradation rate. However, the insufficient osteoblast compatibility has greatly hampered wider applications of this material as bone-replacement materials. Plasma immersion ion implantation (PIII) is one of the surface modification method which is prominent for its simple operations and the non-light-of-sight characteristic. In this manuscript, NH3 and H2O PIII is conducted to modify PBSu surface respectively. X-ray photoelectron spectroscopy (XPS) and contact angle measurements were carried out to reveal the surface characteristics of the treated and control specimens. The in vitro effects of the materials on seeded osteoblasts were detected by cell viability assay, ALP activity test, and real-time PCR analysis. The results showed that both modified samples exhibit better compatibility to osteoblasts than the untreated one. However, from the aspect of osteogenic gene expression of osteoblasts seeded, NH3 PIII PBSu is much better than H2O PIII PBSu. In other words, NH3 PIII is a better method than H2O PIII to modify PBS substrates for being used as bone-replacement materials. We have developed novel nanofiber-like synthetic viruses which can control and guide cell behavior for tissue engineering materials using genetically engineered M13 bacteriophage (viruses). Filamentous M13 phage have several qualities that make them attractive candidates for use as building blocks in tissue engineering scaffolds. The M13 phage has a monodisperse, long-rod shape that enables its self-assembly into directionally ordered liquid crystalline structures. Through genetic engineering, a highdensity array of peptide-based signaling molecules and therapeutic materials can simultaneously be displayed on its major and minor coat proteins. We have engineered M13 bacteriophage to display various signaling peptide that promote cell interaction (IKVAV, RGD) on all 2700 copies of major coat proteins. We will demonstrate that such engineered phage can self assemble into directionally organized structures, which in turn dictate the alignment and direction of cell growth in 2D and 3D tissue engineering matrices. We will also introduce how to identify the novel signaling peptide using viral tissu engineering approaches. The success of our novel virus-based tissue regenerating materials will enable to manipulate cell behavior at the molecular level and regenerating various tissues, and possibly lead to the discovery of cures for challenging diseases such as spinal cord injuries. 
